Loading…
Shree Ganesh Remedies (SGRL)₹608.65−3.26%Pharmaceuticals
At the end of the Jun 2026 quarter, Shree Ganesh Remedies' shareholders were: promoters 72.81%, DIIs 0.52%, public 26.67%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 7,825 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.31% | 69.31% | 69.31% | 69.31% | 70.47% | 72.78% | 72.78% | 72.78% | 72.78% | 72.78% | 72.81% | 72.81% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.52% |
| Public | 30.69% | 30.69% | 30.69% | 30.68% | 29.52% | 27.21% | 27.21% | 27.21% | 27.21% | 27.22% | 27.19% | 26.67% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 7,333 | 7,521 | 7,052 | 7,189 | 8,511 | 8,698 | 8,981 | 9,169 | 8,755 | 8,445 | 8,061 | 7,825 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Chandulal Manubhai Kothia | Promoter | 48.75% | 0.00 |
| Hanshaben Chandubhai Kothia | Promoter | 11.46% | 0.00 |
| Pooja Gunjan Kothia | Promoter | 4.77% | 0.00 |
| Gunjan Chandulal Kothia | Promoter | 3.20% | 0.00 |
| Manubhai Jivabhai Kothiya | Promoter | 1.83% | 0.00 |
| Gunjan Jayantibhai Dhorajiya | Public | 1.71% | 0.00 |
| Hetvi Ketankumar Patel | Promoter | 1.65% | 0.00 |
| V Naga Raja Naidu | Public | 1.28% | 0.00 |
| Parth Chandulal Kothia | Promoter | 1.05% | 0.00 |
| Kothia Ashokkumar Manubhai (Huf) | Promoter | 0.08% | 0.00 |
Promoters held 72.81% of Shree Ganesh Remedies at the end of the Jun 2026 quarter, up 0.03 percentage points from 72.78% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 0.52% (up 0.52 percentage points from 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Shree Ganesh Remedies had 7,825 shareholders at the end of the Jun 2026 quarter, against 9,169 a year earlier.
Gunjan Jayantibhai Dhorajiya (Public) held 1.71% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.